UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



FORM
10-K/A
Amendment No. 1



(Mark One)



|x | ANNUAL
REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|- | ------------------------------------------------------------------------------
|  |                                                                               
|  | For the fiscal year ended: March 31, 2013                                     



| ̈ | TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|- | ----------------------------------------------------------------------------------
|  |                                                                                   
|  | For the transition period from________
to ___________                             



Commission File No.: 333-176581



CORINDUS VASCULAR ROBOTICS, INC.

(Exact name of registrant as specified in its
charter)





|Nevada                                                             |  | 30-0687898                              
|------------------------------------------------------------------ |  | ----------------------------------------
|(State or other jurisdiction
    of incorporation or organization) |  | (I.R.S. Employer Identification
    No.)





309 Waverley Oaks Road, Suite 105, Waltham,
MA 02452

(Address of principal executive offices)



Registrant’s telephone number, including
area code: (508) 653-3335



Securities registered pursuant
to Section 12(b) of the Exchange Act:None



Securities registered pursuant
to Section 12(g) of the Exchange Act: None



Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.Yes  ̈
No x



Indicate
by check mark if the registrant is not requiredto file reports pursuant to Section 13 or Section 15(d) of the Exchange
Act. Yes  ̈ No x



Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes x No  ̈



Indicate by check mark whether the registrant
has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted
and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter
period that the registrant was required to submit and post such files). Yes x No  ̈



Indicate by check mark if disclosure of delinquent
filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained,
to the best of the registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III
of this Form 10-K or any amendment to this Form 10-K.  ̈













Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions
of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2
of the Exchange Act.





| | Large accelerated filer   ̈                       | Accelerated filer   ̈        
| | ------------------------------------------------ | ----------------------------
| |                                                  |                             
| | Non-accelerated filer   ̈                         | Smaller reporting company  x
| | (Do not check if smaller reporting
    company.) |                             



Indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Act). Yes  ̈ No x





The aggregate market value of the voting common
stock held by non-affiliates of the registrant (52,000,000 shares) based on the closing price of the registrant’s common
stock as reported on OTCQB on September 30, 2012, which was the last business day of the registrant’s most recently completed
second fiscal quarter, was $0. For purposes of this computation, all officers, directors, and 10% beneficial owners of the registrant
are deemed to be affiliates.



The number of shares outstanding of the registrant’s
common stock as of July 9, 2013 was 52,000,000.





2









EXPLANATORY NOTE





This Amendment No. 1 to
our Annual Report on Form 10-K for the fiscal year ended March 31, 2013 is being filed to correct the Form 10-K cover page. The
Company does not have securities registered under Section 12(g) of the Securities Exchange Act of 1934. No other information in
our Annual Report on Form 10-K for the fiscal year ended March 31, 2013 is hereby amended.





3







SIGNATURES



Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Company has duly caused this
Report to be signed on its behalf by the undersigned, thereunto duly authorized.

|DATE:   January
    12, 2015 |                                      |                         
|---------------------------- | ------------------------------------ | ------------------------
|                             |                                      |                         
|                             | CORINDUS VASCULAR ROBOTICS,
    INC.
|                             |                                      |                         
|                             | By:                                  | /s/
    David M. Handler
|                             |                                      | David M. Handler        
|                             |                                      | Chief Executive Officer 



4